The BIOFIRE® Respiratory 2.1 plus Panel tests for 19 viruses and 4 bacteria which cause respiratory tract infections with an overall sensitivity and specificity of 97,4% and 99,4% respectively. It works on the BIOFIRE® FILMARRAY® 2.0 and Torch systems, an FDA, CE-IVD, and TGA certified multiplex PCR system. BIOFIRE® FILMARRAY® integrates sample preparation, amplification, detection and analysis into one simple system that requires just 2 minutes of hands-on time, with a total run time of about an hour. Rapid and accurate identification of the causative agent of upper respiratory tract infections may improve patient management by informing timely and effective antibiotic or antiviral therapy, preventing secondary spread of infection, shortening hospital stays and reducing costs of unnecessary ancillary tests.
- Simple: 2 minutes of hands-on time
- Easy: No precise measuring or pipetting required
- Fast: Turnaround time of about an hour
- Comprehensive: 20 target respiratory panel
BioFire Respiratory Panel 2.1 plus (RP2.1plus) is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy BioFire Respiratory Panel 2.1 plus (RP2.1plus) for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring BioFire Respiratory Panel 2.1 plus (RP2.1plus) for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for BioFire Respiratory Panel 2.1 plus (RP2.1plus) or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.